Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anca Zbranca‐Toporas"'
Autor:
Anca Zbranca-Toporas, LENUȚA PROFIRE
Publikováno v:
FARMACIA. 70:410-416
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7059c75c0c94ac26a56df453fd84dd2
https://doi.org/10.31925/farmacia.2022.3.5
https://doi.org/10.31925/farmacia.2022.3.5
Autor:
Gabriella Fabbrocini, Sameer Zimmo, Marni C. Wiseman, Elena Araviiskaia, Delphine Kerob, Monika Arenbergerova, Maryna Anfilova, Elia Roo, Ziad Khamaysi, Olga L. Forero Barrios, Zrinka Bukvić Mokos, Anca Zbranca‐Toporas, Anneke Andriessen, Maja A. Hofmann, Aleksandra Lesiak, Brigitte Dréno, Marita Kosmadaki, Lucie Guerin, Merete Haedersdal
Publikováno v:
Journal of Cosmetic Dermatology
Dréno, B, Araviiskaia, E, Kerob, D, Andriessen, A, Anfilova, M, Arenbergerova, M, Forero Barrios, O L, Bukvić Mokos, Z, Haedersdal, M, Hofmann, M A, Khamaysi, Z, Kosmadaki, M, Lesiak, A, Roó, E, Zbranca-Toporas, A, Wiseman, M C, Zimmo, S, Guerin, L & Fabbrocini, G 2020, ' Nonprescription acne vulgaris treatments : Their role in our treatment armamentarium—An international panel discussion ', Journal of Cosmetic Dermatology, vol. 19, no. 9, pp. 2201-2211 . https://doi.org/10.1111/jocd.13497
Dréno, B, Araviiskaia, E, Kerob, D, Andriessen, A, Anfilova, M, Arenbergerova, M, Forero Barrios, O L, Bukvić Mokos, Z, Haedersdal, M, Hofmann, M A, Khamaysi, Z, Kosmadaki, M, Lesiak, A, Roó, E, Zbranca-Toporas, A, Wiseman, M C, Zimmo, S, Guerin, L & Fabbrocini, G 2020, ' Nonprescription acne vulgaris treatments : Their role in our treatment armamentarium—An international panel discussion ', Journal of Cosmetic Dermatology, vol. 19, no. 9, pp. 2201-2211 . https://doi.org/10.1111/jocd.13497
Background: Acne vulgaris (acne), a common inflammatory skin disorder, has its peak incidence between 14 and 19 years of age, with girls frequently developing acne earlier than boys. Over recent years, persistent acne is becoming more prevalent in ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d34231a7619facb1011cdc5f675f971c
https://www.bib.irb.hr/1260461
https://www.bib.irb.hr/1260461
Autor:
Mihaela Moscalu, Gladiola Petroiu-Andruseac, Cristian Rotariu, Alexandru Pasarica, Anca Zbranca-Toporas, Dragos Sardaru
Publikováno v:
2019 E-Health and Bioengineering Conference (EHB).
Monitoring maternal and fetal physiological signals from early stages of the pregnancy has become a more common practice due to the high risk implications of preterm delivery. This has led to the development of different fetal and maternal biosignal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bda5ac90bbea8c87cbbdc684c47b14b8
https://doi.org/10.1109/ehb47216.2019.8969888
https://doi.org/10.1109/ehb47216.2019.8969888
Autor:
Roman Nowicki, Christopher Griffiths, François Aubin, Kim A. Papp, Benjamin Barankin, Petr Arenberger, Carle Paul, George Sorin Tiplica, Susan Ball, RAMON M PUJOL, Anca Zbranca-Toporas, Jean-Jacques Grob, Melinda Gooderham, Lajos Kemény, Yuri Perlamutrov, José Luis López Estebaranz, Jean-Philippe Lacour, Ronald Vender
Publikováno v:
The Lancet (London), 386, 541-51
The Lancet (London), 386, 9993, pp. 541-51
The Lancet (London), 386, 9993, pp. 541-51
Summary Background Ixekizumab is a humanised monoclonal antibody against the proinflammatory cytokine interleukin 17A. We report two studies of ixekizumab compared with placebo or etanercept to assess the safety and efficacy of specifically targeting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adc981ea31a5c97750f70341f7937ab7
https://doi.org/10.1016/s0140-6736(15)60125-8
https://doi.org/10.1016/s0140-6736(15)60125-8